Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer
Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy of icotinib at routine dose in previously
treated non/light-smoking patients with advanced squamous cell lung cancer.